bf/NASDAQ:IMUX_icon.png

COM:IMUX

Immunic

  • Stock

USD

Last Close

1.11

22/11 21:00

Market Cap

115.30M

Beta: -

Volume Today

779.33K

Avg: -

Company Overview

Metric
Company NameImmunic, Inc.Alkermes plcAnavex Life Sciences Corp.Therini Bio
SymbolIMUXALKSAVXL
MSH IDCOM:IMUXCOM:ALKERMESCOM:ANAVEXCOM:THERINIBIO
MarketSTOCKSSTOCKSSTOCKSPRIVATE
SectorHealthcareHealthcareHealthcareHealthcare & Health Services
IndustryBiotechnologyBiotechnologyBiotechnologyBiotechnology
CountryUSIEUSUS
StagePost-IPO Equity
Employee Count802.10K40
Websiteimmunic-therapeutics.comalkermes.comanavex.comtherinibio.com
LinkedIntherinibio
Founders

Market Metrics

Metric
Market Cap115.30M3.89B391.04M
Enterprise Value
Monthly Web Traffic4.44K
Web Traffic Growth1.34
Valuation
Raised Capital240M

Financial Performance

Metric
Revenue1.66B
Revenue (LTM)
Revenue (NTM)
Gross Profit1.37B
EBITDA486.73M
Operating Income414.12M
Net Income355.76M
EPS2.14
Diluted EPS2.10
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.87
Operating Profit Margin0.22
EBITDA Margin0.29
Net Profit Margin0.25
Return on Equity0.34
Return on Assets0.20
Return on Capital Employed0.23

Valuation Multiples

Metric
P/E Ratio20.48
P/B Ratio3.24
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio3.17
EV Multiple16.57

Operational Metrics

Metric
Days Sales Outstanding78.13
Days Payables Outstanding94.07
Days Inventory Outstanding352.33
Operating Cycle441.02
Cash Conversion Cycle441.02
Asset Turnover0.81

Cash Flow Metrics

Metric
Operating Cash Flow401.35M
Free Cash Flow353.31M
Cash Flow to Debt1.50
Operating Cash Flow/Sales0.29
Free Cash Flow Yield0.06

Balance Sheet Metrics

Metric
Cash & Equivalents457.47M
Accounts Receivable-44.51M
Inventory186.41M
Goodwill83.03M
Debt to Capitalization0.22
Debt to Assets0.13
Current Ratio3.12
Quick Ratio2.77

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.06
R&D to Revenue0.19
SG&A to Revenue0.17